Nyxoah SA (NYXH) has a profit margin of -310.63%, below the Healthcare sector average of 17.63%.
Get informed when a big investor buys or sells
+ FollowAs of Sep 2026
Trailing 12 months ending Sep 2026
The latest profit margin for NYXH is -310.63% as of September 2026. That compares with -1484.66% in the prior-year period — up 79.1% year over year. That is below the Healthcare sector average of 17.63%. Investors often review this figure alongside Nyxoah SA's historical trend and sector peers before judging valuation or financial health.
Over the past year, NYXH's profit margin moved from -1484.66% to -310.63% — a 79.1% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Nyxoah SA's valuation or profitability profile.
Against Healthcare companies, NYXH currently prints -310.63% for profit margin, while the sector average sits near 17.63%. That is roughly 1862.1% below the sector mean. Large gaps often invite a closer look at Nyxoah SA's growth, margins, and balance sheet.
Profit Margin shows how effectively Nyxoah SA converts resources into returns. At -310.63%, NYXH may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -1484.66% in the prior-year period — up 79.1% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting NYXH's profit margin (-310.63%), review year-over-year change from -1484.66%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.